Session Details

[4P]Schizophrenia

Sat. Jul 31, 2021 11:00 AM - 12:00 PM JST
Sat. Jul 31, 2021 2:00 AM - 3:00 AM UTC
Online

[4P-427]Relationship between abnormal retrotransposition and development of schizophrenia in neurons

〇Miyako Ishihara1, Kotaro Sekine1, Masahiro Onoguchi1,2, Michiaki Hamada1,2 (1.Waseda Univ, 2.National Inst. of Advanced Industrial Science and Technology)

[4P-429][11C] K-2, the first Positron Emission Tomography Tracer for AMPA receptors available for living human brain, Characterize patients with schizophrenia.

〇Mai Hatano1, Waki Nakajima1, Tomoyuki Miyazaki1, Tsuyoshi Eiro1, Kotaro Nakano1, Hiroyuki Uchida2, Takuya Takahashi1 (1.Department of Physiology Grad Sch Med, Univ of Yokohama City, Kanagawa, Japan, 2.Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)

[4P-431]Betaine ameliorates schizophrenic traits by functionally compensating for KIF3-based CRMP2 transport

〇Shogo Yoshihara1, Xuguang Xuguang1, Momo Morikawa2, Tadayuki Ogawa1, Sotaro Ichinose1, Hirooki Yabe3, Akiyoshi Kakita4, Manabu Toyoshima2, Yasuto Kunii3, Takeo Yoshikawa2, Yosuke Tanaka1, Nobutaka Hirokawa1 (1.Department of Cell Biology and Anatomy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2.Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Saitama, Japan, 3.Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan and Department of Psychiatry, 4.Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan)

[4P-433]Neonatal NMDA receptor blockade and glutamate decarboxylase 67-kDa isoform haplodeficiency synergistically cause behavioral alterations in rats

〇Kazuyuki Fujihara Fujihara1, Toshikazu Kakizaki1, Yuchio Yanagawa1 (1.Gunma University Graduate School of Medicine, Maebashi, Japan)